• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Center for Biologics Evaluation and Research (CBER) 2001

 

Chapter 1

Center for Biologics Evaluation and Research

Table of Contents

 
 
The various reports found under each of the following headings are only a selection of those occurring during the fiscal year and are not all inclusive. This publication does not encompass all of the activities taken by the FDA to bring about compliance.

 

Biologic Products

Bioresearch Monitoring

Blood

In-Vitro Diagnostic Kits

Tissue

Vaccines

Charts

CBER Enforcement Actions FY 1997-2001

CBER Surveilllance Activity FY 1997-2001

CBER Inspections FY 1997-2001

CBER Foreign Inspections FY 1997-2001

CBER Recalls FY 1997-2001